Akebia Therapeutics, Inc.
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
Other Names/Subsidiaries
- Access Oncology
- AOI Pharma
- Keryx Biopharmaceuticals
Latest on Akebia Therapeutics, Inc.
Contract manufacturing of biologics is one of the few weak points in the typically overwhelming advantage the US holds over Europe in bestowing the first approval for new drug products, a Pink Sheet
The US Food and Drug Administration maintained a high rate of complete response letter actions for novel agent applications in 2024, but recent history suggests that many of the 16 CRL recipients will
The new drugs that hit the market in 2024 included medicines to address an array of high unmet medical need, but the US Food and Drug Administration approval of several drugs for liver disease put a s
The new drugs that hit the market in 2024 included medicines to address an array of high unmet medical need, but the US Food and Drug Administration approval of several drugs for liver disease put a s